CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 284,060 shares at $19.74 ($5.6M) on 2016-06-28, disclosed to the SEC on 2016-06-30.
Open-market purchase of $5.6M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.74 | 50 | $987 | 0.0% |
| 2 | $19.74 | 210 | $4K | 0.1% |
| 3 | $19.74 | 220 | $4K | 0.1% |
| 4 | $19.74 | 310 | $6K | 0.1% |
| 5 | $19.74 | 60 | $1K | 0.0% |
| 6 | $19.74 | 50 |
| $987 |
| 0.0% |
| 7 | $19.74 | 60 | $1K | 0.0% |
| 8 | $19.74 | 310 | $6K | 0.1% |
| 9 | $19.74 | 220 | $4K | 0.1% |
| 10 | $19.74 | 210 | $4K | 0.1% |
| 11 | $19.83 | 21,690 | $430K | 7.7% |
| 12 | $19.83 | 3,690 | $73K | 1.3% |
| 13 | $19.83 | 14,960 | $297K | 5.3% |
| 14 | $19.83 | 4,110 | $81K | 1.5% |
| 15 | $19.83 | 3,550 | $70K | 1.3% |
| 16 | $19.83 | 15,700 | $311K | 5.5% |
| 17 | $19.83 | 4,110 | $82K | 1.5% |
| 18 | $19.83 | 3,550 | $70K | 1.3% |
| 19 | $19.83 | 3,690 | $73K | 1.3% |
| 20 | $19.83 | 14,960 | $297K | 5.3% |
| 21 | $19.83 | 21,690 | $430K | 7.7% |
| 22 | $19.75 | 24,630 | $486K | 8.7% |
| 23 | $19.75 | 6,450 | $127K | 2.3% |
| 24 | $19.75 | 34,010 | $672K | 12.0% |
| 25 | $19.75 | 5,570 | $110K | 2.0% |
| 26 | $19.75 | 23,460 | $463K | 8.2% |
| 27 | $19.75 | 24,630 | $486K | 8.7% |
| 28 | $19.75 | 34,010 | $672K | 12.0% |
| 29 | $19.75 | 5,570 | $110K | 2.0% |
| 30 | $19.75 | 5,880 | $116K | 2.1% |
| 31 | $19.75 | 6,450 | $127K | 2.3% |
| Total | $19.78 avg | 284,060 | $5.6M | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |